Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-19 Sale | 2024-12-20 4:15 pm | Climb Bio Inc. | CLYM | Pimblett Emily CHIEF ACCOUNTING OFFICER | 1,235 | $2.02 | $2,495 | 36,329 (Direct) | View |
| 2024-09-20 Sale | 2024-09-20 9:53 pm | Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER | 1,191 | $8.1791 | $9,741 | 37,564 (Direct) | View |
| 2024-06-20 Sale | 2024-06-21 2:57 pm | Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER | 1,245 | $7.2145 | $8,982 | 38,755 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-18 Exercise | 2024-12-20 4:15 pm | N/A N/A | Climb Bio Inc. | CLYM | Pimblett Emily CHIEF ACCOUNTING OFFICER | 5,000 | $0 | 36,329 (Direct) | View |
| 2024-09-18 Exercise | 2024-09-20 9:53 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER | 5,000 | $0 | 37,564 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-21 2:57 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER | 5,000 | $0 | 38,755 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 4:33 pm | N/A N/A | Eliem Therapeutics Inc. | ELYM | Pimblett Emily CHIEF ACCOUNTING OFFICER | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-03-21 10:21 am | N/A 2031-04-26 | Eliem Therapeutics Inc. | ELYM | Pimblett Emily Chief Accounting Officer | 0 | $0 | 95,000 (Direct) | View |